Scientists reported: “Our results clearly demonstrate that NIDA cannabis samples are substantially genetically different from most commercially available drug-type strains and share a genetic affinity with hemp samples in several of the analyses.”
Author: Paul Armentano, NORML Deputy Director
Goucher polling dating back to 2015 has consistently reported that the majority of Marylanders endorse cannabis legalization.
State officials announced: “Approximately 203,000 marijuana related charges are presently being suppressed from background searches and in process to be sealed or expunged. … This will add to the approximately 198,000 sealing accomplished as part of the first round of marijuana expungements for the 2019 expungement legislation.”
The proposed rules, which must undergo a 60-day public comment period, permit the cultivation of up to six cannabis plants per private residence. The regulations will take effect once the public comment period has ended and the Board has finalized its language.
Justices on the state’s highest court have yet to render a decision regarding the fate of Constitutional Amendment A, the voter-approved initiative which sought to legalize the adult-use possession and sale of cannabis.
Regulators should not be creating undue barriers of entry for those seeking to participate in the legal adult use marketplace. This new rule will encourage more inclusiveness and diversity in Washington’s growing cannabis industry.”
Subcommittee members decided 6 to 4 to eliminate the ability for qualified patients to home-cultivate marijuana. Nearly 70 percent of voters decided in favor of the ballot Measure (Measure 26) last November, which allows patients to either obtain cannabis from state-licensed dispensaries or to grow it themselves.
Patients who are registered with the state’s medical cannabis access program may now legally grow cannabis for their own personal use.